MedDataX Logo

Urinary Marker for Oxidative Stress in Human Cisplatin- Induced Renal Injury

NCT ID: NCT00310739

Last Updated: 2006-11-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Study Classification

OBSERVATIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

We previously reported early measurement of urinary MDA might be a useful marker for the prediction of CDDP-induced renal damage in rat. The purpose of this clinical study is to test whether the changes of human urinary excretion of MDA, and can be used as early biomarker for the prediction of development of CDDP-induced ARF.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Kidney Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

NATURAL_HISTORY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Hospitalized patients have neck cancer
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hamamatsu University

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Takayuki Tsuji, MD

Role: PRINCIPAL_INVESTIGATOR

Hamamatsu University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hamamatsu University School of Medicine

Hamamatsu, Shizuoka, Japan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Japan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Takayuki Tsuji, MD

Role: CONTACT

Phone: +81-53-435-2261

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Takayuki Tsuji, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

16-50

Identifier Type: -

Identifier Source: org_study_id